United States Conjunctivitis (Pink Eye) Drugs Market Report 2016

November 2016 | 112 pages | ID: U0EDA9AD15BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Conjunctivitis (Pink Eye) Drugs

Revenue, means the sales value of Conjunctivitis (Pink Eye) Drugs

This report studies sales (consumption) of Conjunctivitis (Pink Eye) Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Akorn
• Alcon
• Allergan and Bausch & Lomb
• Bayer
• Daiichi Sankyo
• F. Hoffmann-La Roche
• InSite Vision
• Merck
• Nicox
• Novartis
• Perrigo
• Pfizer
• Santen Pharmaceutical
• Shire
• Valeant Pharmaceuticals.
• Sun Pharma.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Conjunctivitis (Pink Eye) Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Conjunctivitis (Pink Eye) Drugs Market Report 2016

1 CONJUNCTIVITIS (PINK EYE) DRUGS OVERVIEW

1.1 Product Overview and Scope of Conjunctivitis (Pink Eye) Drugs
1.2 Classification of Conjunctivitis (Pink Eye) Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Conjunctivitis (Pink Eye) Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Conjunctivitis (Pink Eye) Drugs (2011-2021)
  1.4.1 United States Conjunctivitis (Pink Eye) Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Conjunctivitis (Pink Eye) Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES CONJUNCTIVITIS (PINK EYE) DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Conjunctivitis (Pink Eye) Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Conjunctivitis (Pink Eye) Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Conjunctivitis (Pink Eye) Drugs Average Price by Manufactures (2015 and 2016)
2.4 Conjunctivitis (Pink Eye) Drugs Market Competitive Situation and Trends
  2.4.1 Conjunctivitis (Pink Eye) Drugs Market Concentration Rate
  2.4.2 Conjunctivitis (Pink Eye) Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CONJUNCTIVITIS (PINK EYE) DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Conjunctivitis (Pink Eye) Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Conjunctivitis (Pink Eye) Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Conjunctivitis (Pink Eye) Drugs Price by Type (2011-2016)
3.4 United States Conjunctivitis (Pink Eye) Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CONJUNCTIVITIS (PINK EYE) DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Conjunctivitis (Pink Eye) Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Conjunctivitis (Pink Eye) Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CONJUNCTIVITIS (PINK EYE) DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Akorn
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Akorn Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Alcon
  5.2.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Alcon Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Allergan and Bausch & Lomb
  5.3.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Allergan and Bausch & Lomb Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer
  5.4.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Daiichi Sankyo
  5.5.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Daiichi Sankyo Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 F. Hoffmann-La Roche
  5.6.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 F. Hoffmann-La Roche Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 InSite Vision
  5.7.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 InSite Vision Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Merck
  5.8.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Merck Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Nicox
  5.9.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Nicox Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Novartis
  5.10.2 Conjunctivitis (Pink Eye) Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Novartis Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Perrigo
5.12 Pfizer
5.13 Santen Pharmaceutical
5.14 Shire
5.15 Valeant Pharmaceuticals.
5.16 Sun Pharma.

6 CONJUNCTIVITIS (PINK EYE) DRUGS MANUFACTURING COST ANALYSIS

6.1 Conjunctivitis (Pink Eye) Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Conjunctivitis (Pink Eye) Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Conjunctivitis (Pink Eye) Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Conjunctivitis (Pink Eye) Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CONJUNCTIVITIS (PINK EYE) DRUGS MARKET FORECAST (2016-2021)

10.1 United States Conjunctivitis (Pink Eye) Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Conjunctivitis (Pink Eye) Drugs Sales Forecast by Type (2016-2021)
10.3 United States Conjunctivitis (Pink Eye) Drugs Sales Forecast by Application (2016-2021)
10.4 Conjunctivitis (Pink Eye) Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Conjunctivitis (Pink Eye) Drugs
Table Classification of Conjunctivitis (Pink Eye) Drugs
Figure United States Sales Market Share of Conjunctivitis (Pink Eye) Drugs by Type in 2015
Table Application of Conjunctivitis (Pink Eye) Drugs
Figure United States Sales Market Share of Conjunctivitis (Pink Eye) Drugs by Application in 2015
Figure United States Conjunctivitis (Pink Eye) Drugs Sales and Growth Rate (2011-2021)
Figure United States Conjunctivitis (Pink Eye) Drugs Revenue and Growth Rate (2011-2021)
Table United States Conjunctivitis (Pink Eye) Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Conjunctivitis (Pink Eye) Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjunctivitis (Pink Eye) Drugs Sales Share by Manufacturers
Figure 2016 Conjunctivitis (Pink Eye) Drugs Sales Share by Manufacturers
Table United States Conjunctivitis (Pink Eye) Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Conjunctivitis (Pink Eye) Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Conjunctivitis (Pink Eye) Drugs Revenue Share by Manufacturers
Table 2016 United States Conjunctivitis (Pink Eye) Drugs Revenue Share by Manufacturers
Table United States Market Conjunctivitis (Pink Eye) Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Conjunctivitis (Pink Eye) Drugs Average Price of Key Manufacturers in 2015
Figure Conjunctivitis (Pink Eye) Drugs Market Share of Top 3 Manufacturers
Figure Conjunctivitis (Pink Eye) Drugs Market Share of Top 5 Manufacturers
Table United States Conjunctivitis (Pink Eye) Drugs Sales by Type (2011-2016)
Table United States Conjunctivitis (Pink Eye) Drugs Sales Share by Type (2011-2016)
Figure United States Conjunctivitis (Pink Eye) Drugs Sales Market Share by Type in 2015
Table United States Conjunctivitis (Pink Eye) Drugs Revenue and Market Share by Type (2011-2016)
Table United States Conjunctivitis (Pink Eye) Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Conjunctivitis (Pink Eye) Drugs by Type (2011-2016)
Table United States Conjunctivitis (Pink Eye) Drugs Price by Type (2011-2016)
Figure United States Conjunctivitis (Pink Eye) Drugs Sales Growth Rate by Type (2011-2016)
Table United States Conjunctivitis (Pink Eye) Drugs Sales by Application (2011-2016)
Table United States Conjunctivitis (Pink Eye) Drugs Sales Market Share by Application (2011-2016)
Figure United States Conjunctivitis (Pink Eye) Drugs Sales Market Share by Application in 2015
Table United States Conjunctivitis (Pink Eye) Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Conjunctivitis (Pink Eye) Drugs Sales Growth Rate by Application (2011-2016)
Table Akorn Basic Information List
Table Akorn Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Akorn Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Alcon Basic Information List
Table Alcon Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alcon Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Allergan and Bausch & Lomb Basic Information List
Table Allergan and Bausch & Lomb Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan and Bausch & Lomb Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table InSite Vision Basic Information List
Table InSite Vision Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table InSite Vision Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Nicox Basic Information List
Table Nicox Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nicox Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Perrigo Basic Information List
Table Perrigo Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Perrigo Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Santen Pharmaceutical Basic Information List
Table Santen Pharmaceutical Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Pharmaceutical Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals. Basic Information List
Table Valeant Pharmaceuticals. Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals. Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Sun Pharma. Basic Information List
Table Sun Pharma. Conjunctivitis (Pink Eye) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharma. Conjunctivitis (Pink Eye) Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Conjunctivitis (Pink Eye) Drugs
Figure Manufacturing Process Analysis of Conjunctivitis (Pink Eye) Drugs
Figure Conjunctivitis (Pink Eye) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Conjunctivitis (Pink Eye) Drugs Major Manufacturers in 2015
Table Major Buyers of Conjunctivitis (Pink Eye) Drugs
Table Distributors/Traders List
Figure United States Conjunctivitis (Pink Eye) Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Conjunctivitis (Pink Eye) Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Conjunctivitis (Pink Eye) Drugs Production Forecast by Type (2016-2021)
Table United States Conjunctivitis (Pink Eye) Drugs Consumption Forecast by Application (2016-2021)